In patients with polycythemia vera, those with a hematocrit target of less than 45% had a significantly lower rate of cardiovascular death and major thrombosis than did those with a hematocrit target of 45 to 50%.

Cardiovascular events and intensity of treatment in polycythemia vera.

RUMI, ELISA;
2013-01-01

Abstract

In patients with polycythemia vera, those with a hematocrit target of less than 45% had a significantly lower rate of cardiovascular death and major thrombosis than did those with a hematocrit target of 45 to 50%.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/736419
Citazioni
  • ???jsp.display-item.citation.pmc??? 198
  • Scopus 582
  • ???jsp.display-item.citation.isi??? 550
social impact